Cancer site | Attributable numbers | ||||||
Attributable fraction (%) | Deaths | Registrations | |||||
Male | Female | Total | Male | Female | Male | Female | |
(a) Established carcinogens only (IARC Group 1, strong human evidence) | |||||||
Bladder | 1.3 | 0.6 | 1.0 | 40 | 10 | 89 | 17 |
Leukaemia | 0.3 | 0.5 | 0.2 | 4 | 5 | 5 | 6 |
Lung | 16.5 | 4.5 | 11.6 | 3137 | 599 | 3509 | 680 |
Mesothelioma | 85–90‡ | 20–30‡ | 74–80 | 1450 | 75 | 1450† | 75† |
NMSC | 11.8 | 3.0 | 8.4 | 38 | 6 | 3992 | 855 |
Sinonasal | 34.1 | 10.8 | 23.4 | 24 | 6 | 74 | 18 |
Total | |||||||
Based on deaths | 6.0 | 1.0 | 3.6 | 4693 | 701 | ||
Based on registrations | 5.4 | 1.0 | 3.2 | 9120 | 1652 | ||
(b) Established + uncertain carcinogens (IARC Group 1 and 2A, strong + suggestive human evidence) | |||||||
Bladder | 11.6 | 2.0 | 8.3 | 362 | 32 | 816 | 57 |
Leukaemia | 2.7 | 0.8 | 1.7 | 58 | 11 | 93 | 15 |
Lung | 21.6 | 5.5 | 15.0 | 4106 | 728 | 4594 | 826 |
Mesothelioma | 98* | 90* | 97* | 1650 | 270 | 1650† | 270† |
NMSC | 11.8 | 3.0 | 8.4 | 38 | 6 | 3992 | 855 |
Sinonasal | 64.3 | 18.4 | 43.3 | 45 | 11 | 140 | 31 |
Total: | |||||||
Based on deaths | 8.0 | 1.5 | 4.9 | 6259 | 1058 | ||
Based on registrations | 6.7 | 1.2 | 4.0 | 11 284 | 2054 | ||
Total cancers in GB | 78 237 | 71 666 | 167 506 | 164 586 |
*Includes cases described as due to paraoccupational or environmental exposure to asbestos.
†Taken as equal to attributable deaths for this short-survival cancer.
‡Mid-points of ranges used when estimating attributable numbers and combining results for mesothelioma with the other cancers.
GB, Great Britain; IARC, International Agency for Research on Cancer; NMSC, non-melanoma skin cancer.